Hi
MartyMurray,
KarishmaB, can you please help me with the below Q, maybe my understanding is not 100% correct here.
My issue with option C is that it talks about determining which patient will more likely be saved by the new treatment. Now if the person is "already" a "patient", then why would insurance company sell an insurance to him? If they do, then they need to pay 100% everytime, as person is already a patient. So even if there is a test available to see which method will suit a patient, but it's after someone is diagnosed with cancer!
Patient advocate: A new pancreatic cancer treatment has proven to decrease mortality by 10% over the treatments currently available under your company's insurance plans. Allowing doctors to prescribe the new treatment could save many lives.
Insurer: You fail to recognize that the new treatment is more than twice as expensive as the others. Including the new treatment in our plans would more than double our costs - and therefore dramatically increase premiums - while providing only marginally better care.
Which of the following is an assumption required by the insurer's argument?
(A) Insurance companies should not value the saving of lives more than they value corporate profits.
(B) New treatments should only be included in insurance plans if they increase positive patient outcomes at a higher percentage than they increase costs.
(C) There is no affordable test to determine which patients' lives would be more likely saved by the new treatment than by the old treatment.
(D) No other insurance companies offer the new cancer treatment in their insurance plans.
(E) The pancreatic cancer treatments currently offered by the insurer's plans will not become more effective over time.